Relationship between anxiety, depression, symptom level, and quality of life in individuals with COPD.

Year 2022, Volume: 39 Issue: 1, 144 - 148, 01.01.2022

Özlem Çınar Özdemir Kübra Karadeniz

Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive obstructive pulmonary disease. COPD is a major cause of workforce loss and may affect 7-12% of the adult population. The current study aimed to investigate the relationship between anxiety, depression, symptom level, and quality of life in patients with COPD who were in a stable period. The present study included 125 patients with COPD (66.1±9.011 years) in a stable period. Data were obtained using the St. George Respiratory Questionnaire (SGRQ), Hospital Anxiety and Depression Scale (HAD), and COPD Assessment Test (CAT). There was a significant positive correlation between HAD-anxiety, HAD-depression, HAD-total, CAT, SGRQ-symptom level, and SGRQ-total scores in each pairwise relationship (p<0.05). The present study showed a positive relationship between anxiety, depression, symptom level, and quality of life in patients with COPD who were in a stable period. COPD patients with lower quality of life had higher levels of anxiety, depression, and symptoms. Furthermore, COPD patients with higher symptom levels had higher levels of anxiety and depression. Therefore, multidisciplinary approaches such as breathing exercises and relaxation techniques are remarkable to reduce symptoms and increase the quality of life in patients with COPD.

Keywords

COPD, anxiety, depression, quality of life

References

• 1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy 4ort he diagnosis and management of chronic obstructive pulmonary disease (GOLD), updated 2013.
• 2. Kelly JL, Elkin SL, Fluxman J, Polkey MI, Soljak MA, Hopkinson NS. Breathlessness and skeletal muscle weakness in patients undergoing lung health screening in primary care. Copd. 2013; 10(1): 40-54.
• 3. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population- based prevalence study. Lancet. 2007; 370(9589): 741-750.
• 4. Penña VS, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000; 118(4); 981-989.
• 5. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006; 27(1): 188-207.
• 6. Taytard A, Cousson F. Symptoms and life of patients with chronic bronchitis. Preliminary results. Rev Pneumol Clin. 1996; 52(6): 379-385.
• 7. Siafakas NM. Is dyspnoea the main determinant of quality of life in the failing lung? A review. Eur Respir Rev. 1997; 42 :53-56.
• 8. Gore JM, Brophy CJ, Greenstone AM. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000; 55(12): 1000-1006.
• 9. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(5): 1418-1422.
• 10. Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003; 58(2): 100-105.
• 11. Van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999; 54(8): 688-692.
• 12. McSweeney AJ, Heaton RK, Grant I, Cugell D, Solliday N, Timms R. Chronic obstructive pulmonary disease; socioemotional adjustment and life quality. Chest. 1980; 77(2): 309-311.
• 13. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis. 1992; 145(6): 1321-1327.
• 14. Polatlı M, Yorgancıoğlu A, Aydemir Ö, Demirci NY, Kırkıl G, Naycı SA, et al. St George Solunum Anketinin geçerlilik ve güvenilirliği. Tüberküloz Toraks. 2013; 61(2): 81-87.
• 15. Rutten-van Mölken M, Roos B, Van Noord JA. An empirical comparison of the St George’s Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax. 1999; 54(11): 995–1003.
• 16. Aydemir O. Hastane anksiyete ve depresyon olcegi Turkce formunun gecerlilik ve guvenilirligi. Turk Psikiyatri Derg. 1997; 8: 187-280.
• 17. Yorgancıoğlu A, Polatlı M, Aydemir Ö, Demirci NY, Kırkıl G, Atış SN, et al. KOAH değerlendirme testinin Türkçe geçerlilik ve güvenilirliği. Tuberk Toraks. 2012; 60(4): 314-320.
• 18. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Leidy NK. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009; 34(3): 648-654.
• 19. Elassal G, Elsheikh M, Gawad A, Zeid AGA. Assessment of depression and anxiety symptoms in chronic obstructive pulmonary disease patients: A case – control study. Egypt J Chest Dis Tuberc. 2014; 63(3): 575–582.
• 20. Disler RT, Gallagher RD, Davidson PM. Factors influencing self-management in chronic obstructive pulmonary disease: An integrative review. Int J Nurs Stud. 2012; 49(2): 230–242.
• 21. Laforest L, Roche N, Devouassoux G, Belhassen M, Chouaid C, Ginoux M, et al. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A populationbased cohort study. Respir Med. 2016; 117: 33–39.
• 22. Kendrová L, Kuriplachová G, Ištoňová M, Nechvátal P, Mikuľáková W, Takáč P. Assessment of depression in patients with chronic obstructive pulmonary disease. Kontakt. 2014; 16(3): e203-e208.
• 23. Ohayon MM. Chronic Obstructive Pulmonary Disease and its association with sleep and mental disorders in the general population. J Psychiatr Res. 2014; 54: 79–84.
• 24. Balcells E, Gea J, Ferrer J, Serra I, Orozco-Levi M, de Batlle J, et al. Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes. 2010; 8(1): 1-9.
• 25. Burgel PR, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, et al. Impact of comorbidities on COPD-specific health-related quality of life. Respiratory medicine. 2013; 107(2): 233-241.
• 26. Ekici A, Bulcun E, Karakoc T, Senturk E, Ekici M. Factors associated with quality of life in subjects with stable COPD. Respir Care. 2015; 60(11): 1585-1591.
• 27. Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006; 47(4): 312-319.
• 28. Giardino ND, Curtis JL, Andrei AC, Fan VS, Benditt JO, Lyubkin M, et al. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res. 2010; 11(1): 1-11.
• 29. Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract. 2007; 24(3): 217-223.